TTrialPathMatch Me to Trials
← Back to trials
RecruitingHeart FailureCaregiver Burden

Digital Health Physical Activity Program for Older Family Care Partners of Patents With Heart Failure

Eligible age

50+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of the Aim 3 study is to conduct a pilot randomized controlled trial to assess feasibility and preliminary effects of the TPA4You intervention.

Sponsor: University of Colorado, Denver

You may qualify if…

  • Age greater than or equal to 50 years
  • Involved in caring for a household member aged 50 years or older with the New York Heart Association Class II, III or IV HF
  • Provide at least 8 hours/week of unpaid care for the past 3 months
  • Physically able to engage in structured exercise such as walking, and upper body resistance exercises
  • Engage in \< 30 min of moderate-intensity exercise on fewer than 3 days per week
  • Able to read, speak, and comprehend 5th grade English
  • Own a smartphone
  • Reachable by telephone, text messaging, and email

You may not qualify if…

  • Medical or functional conditions precluding participation in the physical activity (PA) components of the intervention (e.g., inability to walk one block or climb stairs without chest pain, shortness of breath, dizziness; history of falls; or serious or unstable cardiovascular or pulmonary disease)
  • Cognitive impairment (Telephone Interview for Cognitive Status \[TICS\] score \< 25)
  • Inability to use technology
  • Participation in a PA intervention in the previous 6 months
  • Current participation in a PA or behavior change trial
  • Physical activity unpreparedness ('Yes' to any questions 1-4 the Physical Activity Readiness Questionnaire \[PAR-Q\]. If participants respond 'yes' to any questions 5-7, we will ask follow-up questions.)

Where it's recruiting

Colorado

Aurora

Source: ClinicalTrials.gov · NCT05852509 · last updated 2026-01-30